株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

セルフリーDNA (cfDNA) 市場:消耗品・システム/ハードウェア・サービス

Cell-Free DNA (cfDNA): Market Size ad Share Analysis

発行 Kalorama Information 商品コード 408721
出版日 ページ情報 英文 178 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.25円で換算しております。
Back to Top
セルフリーDNA (cfDNA) 市場:消耗品・システム/ハードウェア・サービス Cell-Free DNA (cfDNA): Market Size ad Share Analysis
出版日: 2016年12月31日 ページ情報: 英文 178 Pages
概要

当レポートでは、世界のセルフリーDNA (cfDNA) の市場を調査し、市場の定義と概要、近年の主要市場動向、試薬・消耗品・キット、システム・ソフトウェア、NIPT用製品・サービスの種類と概要、タイプ・地域別の市場規模の推移と予測、機器・消耗品の企業シェア、主な取引・契約、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • NIPT関連事業者など、癌に戦略をシフト
  • 臨床的導入の拡大が高い成長率を支持
  • 政府によるイニシアチブ
  • M&A・エクイティ投資の増加
  • 中国:主要な立場に
  • パーソナライズドメディシン・プロアクティブメディシンの加速
  • 予測されていたシーケンサープラットフォームの停滞・中止
  • 自動化・小型化に向けた積極的取り組み
  • 法規制環境:不明確だか何らかの発展は見られる

第3章 cfDNA分析製品

  • cfDNA試薬・消耗品・キット
  • cfDNAシステム・ソフトウェア
  • cfDNA NIPT製品・サービス
  • 腫瘍・移植・その他の疾患におけるcfDNA
  • cfDNAのその他の製品
  • 近年の製品・サービスの紹介

第4章 市場分析

  • 収益予測
  • 市場規模・予測
  • cfDNA臨床診断市場
  • cfDNA市場:地域別
  • 収益:製品タイプ別
  • 指標としてのIlluminaシーケンシングの収益

第5章 企業プロファイル

第6章 課題・戦略的提言

  • 課題
  • 戦略的提言

第7章 cfDNA分析市場:各種取引・契約

目次
Product Code: KLI15188961

The use of cell-free DNA (cfDNA) and “liquid biopsies” of other analytes has received a huge amount of attention in recent years, due to its potential to revolutionize the diagnosis and treatment of several conditions. The main areas where cfDNA analysis has turned into a major application include non-invasive prenatal testing (NIPT); oncology, circulating tumor DNA (ctDNA); and transplantation, donor-derived cell-free DNA (ddcfDNA).

Cell-Free DNA (cfDNA) Markets focuses on the market for cfDNA analysis instruments, consumables, kits, and related software, which includes the sample preparation products and equipment as well as the next generation sequencing (NGS) and digital polymerase chain reaction (dPCR) systems used for detection. The report provides complete market information, including current market estimates and forecasts to 2021, as well as:

  • Growth Rate for cfDNA Market, 2016-2021
  • cfDNA Clinical Diagnostics Market, 2016-2021
  • cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021
  • cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
  • cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems/hardware, Services)
  • Market Share by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2016

The report provides information on cfDNA analysis products, commenting not only on reagents, consumables, kits, systems, software, and services, but also on oncology cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.

In the cfDNA market there are many technical challenges to overcome, along with a range of competitive, regulatory, and IP issues. Cancer is a dynamic and defiant disease. While NIPT is a proven application, oncology will require much more difficult work and is more uncertain. The variety of potential issues and threats in the market are covered in the challenges and strategic recommendations chapter of the report. The competitive situation, deals, and litigation are covered in respective chapters as well.

Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services. The report profiles those companies competing in the cfDNA instruments and consumables market, including:

  • Agilent Technologies
  • Bio-Rad
  • F. Hoffmann-La Roche AG
  • Fluidigm
  • Illumina
  • Qiagen
  • RainDance Technologies
  • Thermo Fisher Scientific

The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • NIPT, Oncology Leading Market Forward
  • Sensitivity Benefits of dPCR, qPCR, NGS
  • Challenges, Biological and Technologies Limitations
  • Scope and Methodology

CHAPTER TWO: INTRODUCTION

  • NIPT Companies, Others Shifting Strategies to Cancer
  • Expanding Clinical Adoption Sustains High Growth
  • Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas
  • Mergers, Acquisitions, Equity Investments Increasing
  • China Becoming Major Player in Market
  • Personalized, Proactive Medicine Gaining Momentum
  • Expected Sequencer Platforms Stalled or Cancelled
  • Significant Efforts in Automation, Miniaturization
  • Regulatory Situation Unclear But Evolving Somewhat

CHAPTER THREE: CFDNA PRODUCTS

  • cfDNA Reagents, Consumables, and Kits
  • cfDNA Systems and Software
  • cfDNA NIPT Products and Services
  • cfDNA in Oncology, Transplantation and Other Diseases
  • cfDNA Other Products
  • Recent Product/ Service Introductions
  • 2016
  • 2015

CHAPTER FOUR: MARKET SIZE AND SHARE ANALYSIS

  • Revenues Forecast
  • Market Size and Forecast
  • cfDNA Clinical Diagnostics Market
  • cfDNA Market by Region
  • Revenues by Product Type
  • Illumina Sequencing Revenues as Indicator

CHAPTER FIVE: CORPORATE PROFILES

  • Agilent Technologies
  • F. Hoffmann-La Roche AG
  • Fluidigm
  • Illumina
  • Qiagen
  • RainDance Technologies
  • Thermo Fisher Scientific

CHAPTER 6: CHALLENGES AND STRATEGIC RECOMMENDATIONS

  • Challenges
  • Strategic Recommendations

List of Exhibits

  • Chapter 3: cfDNA Analysis Products
  • Table 3-1: cfDNA Reagents, Consumables, and Kits
  • Table 3-2: cfDNA Systems and Software
  • Table 3-3: cfDNA NIPT Products and Services
  • Table 3-4: Oncology cfDNA Products
  • Table 3-5: cfDNA Transplantation Diagnostics
  • Table 3-6: cfDNA Other Products
  • Chapter 4: Market Analysis
  • Figure 4-1: Cost of Sequencing a Genome
  • Table 4-1: Market for cfDNA
  • Figure 4-2: cfDNA Market, 2015-2021
  • Table 4-2: Growth Rate for cfDNA Market, 2015-2021
  • Figure 4-3: Growth Rate in cfDNA Market, 2016-2020
  • Table 4-3: cfDNA Clinical Diagnostics Market, 2015-2021
  • Table 4-4: cfDNA Clinical Diagnostics Market Growth Rate, 2015-2021
  • Table 4-5: cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
  • Figure 4-4: cfDNA Market by Region, 2015 (%) (N. America, Europe, Asia-Pacific & ROW)
  • Table 4-6: cfDNA Instruments and Consumables Revenues by Product Type,2015 (Consumables, Systems/hardware, Services)
  • Figure 4-5: Breakout of cfDNA Market by Type, 2015 (%) (Consumables,Systems/hardware, Services)
  • Table 4-7: Illumina Quarterly Sequencing Revenues (2012-2016)
  • Figure 4-6: Illumina Quarterly Consumables Revenues (2012-2016)
  • Table 4-8: Illumina Annual Consumables Revenues (2012-2015)
  • Table 4-9: Illumina Consumables Growth Rates (2013-2015)
  • Chapter 7: cfDNA Analysis Market Deals
  • Table 7-1: cfDNA Analysis Market Deals
Back to Top